These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 9726240)

  • 41. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.
    Nunn DL; Watson SP
    Biochem J; 1987 May; 243(3):809-13. PubMed ID: 2821994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin.
    Ishizuka T; Taniguchi O; Yamamoto M; Kajita K; Nagashima T; Takeda N; Inouye H; Yasuda K; Miura K
    Diabetologia; 1994 Jun; 37(6):632-8. PubMed ID: 7926350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterisation of Rac activation in thrombin- and collagen-stimulated human blood platelets.
    Soulet C; Gendreau S; Missy K; Benard V; Plantavid M; Payrastre B
    FEBS Lett; 2001 Nov; 507(3):253-8. PubMed ID: 11696351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
    Krishnamurthi S; Patel Y; Kakkar VV
    Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
    Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of human platelet protein kinase C by endotoxic lipid A.
    Grabarek J; Timmons S; Hawiger J
    J Clin Invest; 1988 Sep; 82(3):964-71. PubMed ID: 3047171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts.
    Uchida K; Ogino K; Shimoyama M; Hisatome I; Shigemasa C
    Eur J Pharmacol; 2000 Jul; 400(1):113-9. PubMed ID: 10913592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin.
    Cho MJ; Pestina TI; Steward SA; Lowell CA; Jackson CW; Gartner TK
    Blood; 2002 Apr; 99(7):2442-7. PubMed ID: 11895777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.
    Martinson EA; Scheible S; Greinacher A; Presek P
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):623-8. PubMed ID: 7544577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats.
    Isshiki K; Haneda M; Koya D; Maeda S; Sugimoto T; Kikkawa R
    Diabetes; 2000 Jun; 49(6):1022-32. PubMed ID: 10866056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein kinase C-delta activation and tyrosine phosphorylation in platelets.
    Moussazadeh M; Haimovich B
    FEBS Lett; 1998 Nov; 438(3):225-30. PubMed ID: 9827550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors.
    Puri RN; Colman RW
    Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet activity and phosphoinositide turnover increase with advancing age.
    Bastyr EJ; Kadrofske MM; Vinik AI
    Am J Med; 1990 Jun; 88(6):601-6. PubMed ID: 2161185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
    Fulgencio JP; Kohl C; Girard J; Pégorier JP
    Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of chlorpromazine on secretion, protein phosphorylation and phosphoinositide metabolism in stimulated platelets.
    Opstvedt A; Rongved S; Aarsaether N; Lillehaug JR; Holmsen H
    Biochem J; 1986 Aug; 238(1):159-66. PubMed ID: 3026339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.